Bearing variant alleles at uridine glucuronosyltransferase polymorphisms UGT2B7 -161C > T (rs7668258) or UGT1A43 c.142 T > G (rs2011425) has no relevant consequences for lamotrigine troughs in adults with epilepsy

Purpose To estimate whether epilepsy patients with variant UGT2B7 -161C  >  T (rs7668258) or UGT1A4*3 c.142 T  >  G (rs2011425) alleles differ from their wild-type (wt) peers in exposure to lamotrigine. Methods Consecutive adults on lamotrigine monotherapy or lamotrigine + valproate co-treatme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of clinical pharmacology 2023-08, Vol.79 (8), p.1117-1129
Hauptverfasser: Božina, Nada, Sporiš, Ivana Šušak, Domjanović, Iva Klarica, Ganoci, Lana, Šimičević, Livija, Lovrić, Mila, Romić, Zrinka Čolak, Gadže, Željka Petelin, Trkulja, Vladimir
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To estimate whether epilepsy patients with variant UGT2B7 -161C  >  T (rs7668258) or UGT1A4*3 c.142 T  >  G (rs2011425) alleles differ from their wild-type (wt) peers in exposure to lamotrigine. Methods Consecutive adults on lamotrigine monotherapy or lamotrigine + valproate co-treatment undergoing routine therapeutic drug monitoring, otherwise generally healthy and free of interacting drugs, were genotyped for UGT2B7 -161C  >  T and UGT1A4*3 c.142 T  >  G. Heterozygous, variant homozygous, or combined heterozygous/variant homozygous subjects were compared to their wt controls for dose-adjusted lamotrigine troughs with adjustment for age, sex, body weight, rs7668258/rs2011425, polymorphisms of efflux transporter proteins ABCG2 c.421C  >  A (rs2231142) and ABCB1 1236C  >  T (rs1128503), and level of exposure to valproate using covariate entropy balancing. Results Of the 471 included patients, 328 (69.6%) were on monotherapy and 143 were co-treated with valproate. Dose-adjusted lamotrigine troughs in UGT2B7 -161C  >  T heterozygous (CT, n  = 237) or variant homozygous (TT, n  = 115) subjects were closely similar to those in their wt controls (CC, n  = 119): geometric means ratios (GMRs) (frequentist and Bayes) 1.00 (95%CI 0.86–1.16) and 1.00 (95%CrI 0.83–1.22) for CT vs. CC; and 0.97 (0.81–1.17) and 0.97 (0.80–1.20) for TT vs. CC subjects. Lamotrigine troughs were also closely similar in UGT1A4*3 c.142 T  >  G variant carriers ( n  = 106: 102 TG + 4 GG subjects) and wt controls (TT, n  = 365): GMR = 0.95 (0.81–1.12) frequentist, 0.96 (0.80–1.16) Bayes. GMRs for variant carriers vs. wt controls were around unity also at different levels of exposure to valproate. Conclusion Dose-adjusted lamotrigine troughs in epilepsy patients with variant UGT2B7 -161C  >  T or UGT1A4*3 c.142 T  >  G alleles are equivalent to those in their respective wt peers.
ISSN:0031-6970
1432-1041
DOI:10.1007/s00228-023-03526-z